Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naghmeh Khavandgar"'
Autor:
Tahereh Rostami, Mohammad Reza Rostami, Amir Hossein Mirhosseini, Saeed Mohammadi, Mohsen Nikbakht, Hediyeh Alemi, Naghmeh Khavandgar, Soroush Rad, Ghasem Janbabai, Seied Asadollah Mousavi, Azadeh Kiumarsi, Amir Kasaeian
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Background Graft failure (GF) is a rare but serious complication after allogeneic hematopoietic stem cell transplantation (HSCT). Prevention of graft failure remains the most advisable approach as there is no clear recommendation for the bes
Externí odkaz:
https://doaj.org/article/a62643ea6d84453486fc947c6e864734
Autor:
Tahereh Rostami, Soroush Rad, Mohammad Reza Rostami, Seied Amirhossein Mirhosseini, Hediyeh Alemi, Naghmeh Khavandgar, Ghasem Janbabai, Azadeh Kiumarsi, Amir Kasaeian, Seied Asadollah Mousavi
Publikováno v:
Cell Transplantation, Vol 33 (2024)
While exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia) have been approved by the US Food and Drug Administration (FDA) as the first cell-based gene therapies for the treatment of patients 12 years of age and older with sic
Externí odkaz:
https://doaj.org/article/9f52a335cb7b4336aa1360bddbf0e751
Autor:
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, Faezeh Shekari, Seyedeh-Esmat Hosseini, Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Hamidreza Jamaati, Naghmeh Khavandgar, Hediyeh Alemi, Hoda Madani, Abdoreza Nazari, Azadeh Amini, Seyedeh Nafiseh Hassani, Fatemeh Abbasi, Neda Jarooghi, Nasrin Fallah, Leila Taghiyar, Meysam Ganjibakhsh, Ensiyeh Hajizadeh-Saffar, Massoud Vosough, Hossein Baharvand
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract Background and aims The main causes of death in patients with severe Coronavirus disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan failure caused by a severe inflammatory cascade. Novel treatment strategie
Externí odkaz:
https://doaj.org/article/7df00c381fdb4b738a4e0dd6dfc12c45
Autor:
Sahar Tavakoli, Fattaneh Khalaj, Amir Kasaeian, Seyed Ali Mousavi, Amir-Hossein Mousavian, Fatemeh Arabi, Soroush Rad, Shahrbano Rostami, Maryam Barkhordar, Mohammad Biglari, Heydar Ali Mardani-Fard, Hediyeh Alemi, Naghmeh Khavandgar, Hossein Kamranzadeh Fumani, Ghasem Janbabai, Seied Asadollah Mousavi, Ardeshir Ghavamzadeh, Mohammad Vaezi
Publikováno v:
Cell Transplantation, Vol 32 (2023)
Imatinib, a selective BCR-ABL tyrosine kinase inhibitor (TKI), was introduced after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with chronic myeloid leukemia (CML). However, the long-term effects of allo-HSCT in chroni
Externí odkaz:
https://doaj.org/article/e40663e1c40e47438e41d2cb876bfcaf
Autor:
Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi, Masoud Soleimani, Massoud Vosough, Seyedeh-Esmat Hosseini, Hamed Hossieni, Saeid Heidari Keshel, Zeinab Naderpour, Ensiyeh Hajizadeh-Saffar, Elham Shajareh, Hamidreza Jamaati, Mina Soufi-Zomorrod, Naghmeh Khavandgar, Hediyeh Alemi, Aliasghar Karimi, Neda Pak, Negin Hossieni Rouzbahani, Masoumeh Nouri, Majid Sorouri, Ladan Kashani, Hoda Madani, Nasser Aghdami, Mohammad Vasei, Hossein Baharvand
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-12 (2021)
Abstract Background Acute respiratory distress syndrome (ARDS) is a fatal complication of coronavirus disease 2019 (COVID-19). There are a few reports of allogeneic human mesenchymal stem cells (MSCs) as a potential treatment for ARDS. In this phase
Externí odkaz:
https://doaj.org/article/6c478e3e60944ae99b138d85d5c1ff70
Autor:
Ladan Kashani, Mina Soufizomorrod, Rasoul Aliannejad, Ensiyeh Hajizadeh-Saffar, Seyed-Mohammad Reza Hashemian, Aliasghar Karimi, Hamidreza Jamaati, Hamed Hossieni, Nasser Aghdami, Negin Hossieni Rouzbahani, Hoda Madani, Massoud Vosough, Seyedeh-Esmat Hosseini, Hediyeh Alemi, Neda Pak, Mohammad Vasei, Masoud Soleimani, Hossein Baharvand, Morteza Zarrabi, Masoumeh Nouri, Zeinab Naderpour, Elham Shajareh, Majid Sorouri, Naghmeh Khavandgar, Saeid Heidari Keshel
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-12 (2021)
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-12 (2021)
Background Acute respiratory distress syndrome (ARDS) is a fatal complication of coronavirus disease 2019 (COVID-19). There are a few reports of allogeneic human mesenchymal stem cells (MSCs) as a potential treatment for ARDS. In this phase 1 clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1f31a8f58f9b392239c47c81fbb7fd
https://doi.org/10.1186/s13287-021-02165-4
https://doi.org/10.1186/s13287-021-02165-4